News-Medical.Net on MSN10d
Targeting MARCO enhances cancer immunotherapy effectivenessResearchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression
Inhibition of the CSF1-CSF1R axis, a major research direction of macrophage-targeted immunotherapy, led to the depletion of the protective C1QC + macrophage subset while sparing malignant SPP1 ...
The most advanced are agents that target the colony-stimulating factor 1 receptor (CSF-1R), but these agents mainly cause macrophage depletion and show substantial toxicity over time.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...
A research team led by Prof. Zeng Zhutian from the University of Science and Technology of China (USTC) has identified and ...
SPP1+ Macrophages Identified as Key Drivers and Therapeutic Targets In Colorectal Cancer Progression
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback